Vanguard Group Inc Nexgel, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Nexgel, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 49,975 shares of NXGL stock, worth $190,404. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,975
Previous 28,626
74.58%
Holding current value
$190,404
Previous $61,000
109.84%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NXGL
# of Institutions
14Shares Held
233KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA56.8KShares$216,5600.0% of portfolio
-
Simon Quick Advisors, LLC35.7KShares$136,0740.01% of portfolio
-
Northeast Financial Group, Inc. Tannersville, PA31.8KShares$121,3400.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny28.5KShares$108,4130.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA19.3KShares$73,4980.0% of portfolio
About NEXGEL, INC.
- Ticker NXGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 5,572,230
- Market Cap $21.2M
- Description
- NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...